Aradhye Shreeram 4
4 · Dicerna Pharmaceuticals Inc · Filed Jan 12, 2021
Insider Transaction Report
Form 4
Aradhye Shreeram
EVP & Chief Medical Officer
Transactions
- Award
Restricted Stock Units
2021-01-12+11,350→ 11,350 total→ Common Stock (11,350 underlying) - Award
Employee Stock Option (Right to Buy)
2021-01-12+51,070→ 51,070 totalExercise: $24.05Exp: 2031-01-11→ Common Stock (51,070 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Common Stock.
- [F2]The RSUs vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of December 15, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer through the applicable vesting date.
- [F3]The option vests in 48 substantially equal monthly installments, with the first installment vesting on the last day of January 2021, and the remaining shares vesting on the last day of each of the 47 months thereafter; subject in each case to the Reporting Person's continued employment or service with the Issuer through each applicable vesting date.